文献速递消化内镜消化道肿瘤与早癌

新型关节刀内镜黏膜下剥离术治疗食管肿瘤的安全性与组织学结局

Safety and histologic outcomes of endoscopic submucosal dissection with a novel articulating knife for esophageal neoplasia.
PubMed 文献 · Gastrointest Endosc · 2019-12-20

该回顾性研究比较了新型关节刀内镜黏膜下剥离术(ESD-AR)与广泛EMR治疗≥15mm食管病变的安全性和组织学诊断。结论认为经验丰富的内镜医师行ESD-AR安全性可与EMR媲美,且可能有利于诊断分期。

要点

  • ESD-AR与EMR治疗≥15mm食管病变安全性相当,均无穿孔。
  • ESD-AR不良事件率3%,与抗凝使用和较大切除面积相关。

核心结论

  • 经验丰富的内镜医师行ESD-AR治疗大食管肿瘤的安全性可与广泛EMR相媲美。
  • ESD-AR可能在诊断分期方面具有优势。

研究设计与样本

  • 回顾性研究,纳入临床指征的ESD-AR和EMR治疗食管病变≥15mm的病例。
  • ESD-AR组72例,EMR组72例,所有EMR病例至少同时进行3处EMR以充分比较切除面积。

主要发现

  • 两组在年龄、性别、Barrett食管长度、病变或切除大小方面无统计学差异。

临床怎么用

  • 对于≥15mm的食管肿瘤,经验丰富的内镜医师可考虑使用ESD-AR,其安全性不劣于EMR。
  • ESD-AR可能提供更准确的诊断分期,有助于后续治疗决策。

局限性

  • 回顾性研究设计。
  • 样本量有限(每组72例)。
  • 所有操作由经验丰富的内镜医师完成,结果可能不可推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Treatment of large esophageal neoplasia is gradually evolving from piecemeal to en bloc resections. Endoscopic submucosal dissection (ESD) is known to achieve more complete resections than piecemeal EMR for large lesions, yet it remains underused in the West because of technical and safety concerns with traditional electrosurgical knives. We aimed to evaluate a novel endoscopic articulating knife used with ESD (ESD-AR) to determine its safety and efficacy for large esophageal neoplasms in comparison with EMR. METHODS: We retrospectively studied clinically indicated cases of ESD-AR and EMR for esophageal lesions that were 15 mm or greater. All EMR cases had at least 3 simultaneous EMRs to adequately compare resection area. Rates of perforation, GI bleeding, technical performance, and pre- and postendoscopic resection diagnoses were evaluated. RESULTS: Seventy-two ESD-AR and 72 widespread EMR cases were evaluated for Barrett's esophagus (56%), adenocarcinoma (36%), squamous nodularity (2%), and squamous cell carcinoma (6%). There were no statistical differences in age, sex, Barrett's esophagus length, and lesion or resection size between the 2 groups. No perforations occurred. Two adverse events were recorded with ESD-AR and none with EMR (3% vs 0%, P = .50); these were associated with anticoagulation use (P = .04) and greater resection area (P = .02). There were more upgraded diagnoses post-ESD versus EMR (27% vs 12%, P = .05). CONCLUSIONS: ESD-AR by an experienced endoscopist has a comparable safety profile with widespread EMR for large esophageal neoplasia and may have advantages for diagnostic staging.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Genere JR, Priyan H, Sawas T, et al. Safety and histologic outcomes of endoscopic submucosal dissection with a novel articulating knife for esophageal neoplasia. Gastrointest Endosc. 2019. PMID: 31870824. doi:10.1016/j.gie.2019.12.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。